A. Rachlis

M. Wainberg, C. Tremblay, S. Walmsley, 2010, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

A Comparison of Virological Suppression and Rebound between Indigenous and Non-Indigenous Persons Initiating Combination Antiretroviral Therapy in a Multisite Cohort of Individuals Living with HIV in Canada

R. Hogg, J. Montaner, A. Burchell, 2016, Antiviral therapy.

HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality

E. Moodie, D. Rouleau, B. Conway, 2013, HIV medicine.

Epidemiology and prevalence of onychomycosis in HIV‐positive individuals

A. Rachlis, R. Summerbell, M. Gupta, 2000, International journal of dermatology.

Is there a reservoir of sub-clinical lymphogranuloma venereum and non-LGV Chlamydia trachomatis infection in men who have sex with men?

C. Kovacs, T. Wong, A. Rachlis, 2008, International journal of STD & AIDS.

Symptomatic primary HIV infection or risk experiences? Circumstances surrounding HIV testing and diagnosis among recent seroconverters

A. Burchell, T. Myers, J. Raboud, 2003, International journal of STD & AIDS.

SARS outbreak in the Greater Toronto Area: the emergency department experience

M. Schull, S. Walmsley, A. Rachlis, 2004, Canadian Medical Association Journal.

Investigation of fatigue.

A. Rachlis, B. Berris, 1977, Canadian family physician Medecin de famille canadien.

Safety, Tolerability, and Efficacy of Darunavir (TMC114) with Low-Dose Ritonavir in Treatment-Experienced, Hepatitis B or C Co-infected Patients in POWER 1 and 3

B. Clotet, A. Rachlis, R. Murphy, 2007, HIV clinical trials.

Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada

R. Hogg, J. Montaner, A. Burchell, 2017, Canadian Journal of Public Health.

Is any job better than no job? Labor market experiences and depressive symptoms in people living with HIV

S. Rourke, A. Rachlis, N. Mittmann, 2015, AIDS care.

Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis

A. Rachlis, R. Pinto, S. Mubareka, 2012, Infection Control & Hospital Epidemiology.

Reduced Plasma Concentrations of Antituberculosis Drugs in Patients with HIV Infection

A. Rachlis, G. Garber, S. Tailor, 1997, Annals of Internal Medicine.

Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.

J. Singer, M. Gill, S. Walmsley, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Flow cytometry in the management of infection with human immunodeficiency virus.

A. Rachlis, P. Pinkerton, M. Reis, 1995, Transfusion science.

Effectiveness of Step-Wise Intervention Plan for Managing Nelfinavir-Associated Diarrhea: A Pilot Study

J. Macleod, S. Walmsley, A. Rachlis, 2005, HIV clinical trials.

Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).

S. Walmsley, A. Rachlis, S. Read, 1988, The Journal of infectious diseases.

High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV

A. Ferenczy, J. Fontaine, A. Rachlis, 2005, AIDS.

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America

Sally S Bebawy, Richard D Moore, J. Goedert, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.

Richard D Moore, J. Goedert, B. Lau, 2016, The Journal of infectious diseases.

Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study

Richard D Moore, J. Goedert, R. Hogg, 2013, Journal of acquired immune deficiency syndromes.

New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals.

I. James, S. Mallal, J. Montaner, 2020, Human immunology.

External Quality Assessment of HLA-B*5701 Reporting: An International Multicentre Survey

S. Mallal, M. Gill, C. Mamotte, 2007, Antiviral therapy.

Bowel loops and eyelid droops

D. Cescon, A. Rachlis, J. Austin, 2008, Canadian Medical Association Journal.

A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector® vs standard needles for enfuvirtide administration *

J. Montaner, C. Kovacs, D. Rouleau, 2007, HIV medicine.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Increase in transmitted HIV drug resistance among persons undergoing genotypic resistance testing in Ontario, Canada, 2002-09.

A. Burchell, S. Rourke, A. Rachlis, 2012, The Journal of antimicrobial chemotherapy.

Nonfinancial Factors Associated With Decreased Plasma Viral Load Testing in Ontario, Canada

J. Raboud, A. Rachlis, A. Bayoumi, 2005, Journal of acquired immune deficiency syndromes.

Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients

R. Ebrahimi, A. Rachlis, Samir K. Gupta, 2014, PloS one.

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

Richard D Moore, J. Goedert, Jeffrey N. Martin, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of and risk factors for tenofovir‐induced nephrotoxicity: a retrospective cohort study

T. Antoniou, M. Loutfy, J. Raboud, 2005, HIV medicine.

Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trial

A. Burchell, V. Allen, Darrell H S Tan, 2020, BMC Health Services Research.

Management of Community-Acquired Pneumonia at a Tertiary-Care Teaching Hospital

A. Rachlis, S. Walker, R. Minhas, 2006 .

A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection

J. Singer, M. Gill, B. Conway, 2022, PloS one.

Cyclosporine-induced deterioration in patients with AIDS.

M. Wainberg, S. Walmsley, A. Rachlis, 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Burden and risk factors for gastrointestinal symptom distress in HIV patients in the modern antiretroviral era

T. Hart, A. Burchell, S. Rourke, 2017, AIDS care.

Infection in hospitalized trauma patients: incidence, risk factors, and complications.

J. Szalai, A. Rachlis, B. McLellan, 1999, The Journal of trauma.

Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelines.

M. Wainberg, C. Tremblay, A. Rachlis, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

ANTI-RETROVIRAL TREATMENT: SIDE EFFECT MANAGEMENT

A. Rachlis, 1991 .

Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care

R. Hogg, J. Montaner, A. Burchell, 2015, Journal of the International AIDS Society.

Factors associated with virological suppression among HIV‐positive individuals on highly active antiretroviral therapy in a multi‐site Canadian cohort

A. Rachlis, J. Montaner, C. Tsoukas, 2011, HIV medicine.

Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial

D. Kuritzkes, D. Ward, R. Wong, 1998, AIDS.

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, R. Hogg, 2017, BMC Research Notes.

Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia.

E. Franco, A. Ferenczy, A. Rachlis, 2008, The Journal of general virology.

Syphilis serology in human immunodeficiency virus-infected patients with symptomatic neurosyphilis: case report and review.

A. Rachlis, A. Matlow, 1990, Reviews of infectious diseases.

Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV.

A. Ferenczy, J. Fontaine, A. Rachlis, 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Microbiological surveillance and parenteral antibiotic use in a critical care unit.

A. Rachlis, M. Louie, A. Simor, 2000, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Case Series of Fertility Treatment in HIV-Discordant Couples (Male Positive, Female Negative): The Ontario Experience

M. Loutfy, A. Rachlis, Denise Jaworsky, 2011, PloS one.

Learning from Interviews with HIV-Discordant Couples (Male Positive, Female Negative): The Challenges and Successes

M. Loutfy, A. Rachlis, Denise Jaworsky, 2011, The open AIDS journal.

Cumulative Incidence of Cancer among HIV-infected Individuals in North America

J. Goedert, B. Lau, R. Hogg, 2016 .

Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study.

Hong Yang, J. Montaner, D. Rouleau, 2010, International journal of epidemiology.

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.

A. Rachlis, 1992, The New England journal of medicine.

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy

B. Yip, R. Hogg, J. Montaner, 2017, BMC Infectious Diseases.

Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS).

A. Burchell, M. Loutfy, S. Rourke, 2013, International journal of epidemiology.

Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study

A. Burchell, M. Gill, S. Letendre, 2016, Journal of NeuroVirology.

Impact of Age on Retention in Care and Viral Suppression

Richard D Moore, K. Anastos, A. Burchell, 2015, Journal of acquired immune deficiency syndromes.

A Latent Class Analysis of the Social Determinants of Health Impacting Heavy Alcohol Consumption Among Women Living with HIV in Canada: The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, A. Burchell, 2019, AIDS and Behavior.

Antiviral therapy.

A. Rachlis, A R Rachlis, 1989, Clinics in dermatology.

A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.

L. Mandell, T. Louie, J. Pater, 1985, Archives of internal medicine.

Mycoplasma infection of the hand acquired from a cat.

A. Rachlis, H. Ruhnke, S. Mccabe, 1987, The Journal of hand surgery.

Mycobacterium xenopi infection in patients with human immunodeficiency virus infection.

S. Walmsley, A. Rachlis, I. Fong, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.

J. Singer, M. Gill, S. Walmsley, 1996, The New England journal of medicine.

Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.

A. Rachlis, R. Feld, G. DeBoer, 1984, Archives of internal medicine.

Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial

S. Trottier, A. Winston, B. Conway, 2018, The Journal of antimicrobial chemotherapy.

A cryptic cause of cryptococcal meningitis.

S. Shumak, A. Rachlis, M. Cheung, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Analysis of Spontaneous Reports of Hypoglycemia and Hyperglycemia Associated with Marketed Systemic Fluoroquinolones Made to the Canadian Adverse Drug Reaction Monitoring Program

S. Knowles, E. Phillips, A. Rachlis, 2004 .

Treatment with letrazuril of refractory cryptosporidial diarrhea complicating AIDS.

S. Walmsley, A. Rachlis, I. Fong, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis

Richard D Moore, J. Goedert, K. Anastos, 2013, Journal of acquired immune deficiency syndromes.

Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.

A. Ferenczy, J. Raboud, S. Walmsley, 2013, The Journal of infectious diseases.

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

J. van Lunzen, A. Rieger, A. Antinori, 2016, AIDS.

Principal Investigator: Dr. Marina B. Klein

J. Montaner, M. Ostrowski, D. Rouleau, 2008 .

Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals

T. Hart, S. Rourke, J. Raboud, 2013, Quality of Life Research.

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study

S. Trottier, B. Conway, M. Loutfy, 2013, BMC Infectious Diseases.

Foscarnet Therapy of Cytomegalovirus Retinitis in AIDS

V. Kozousek, A. Matlow, S. Walmsley, 1990, Journal of acquired immune deficiency syndromes.

Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapy.

C. Kovacs, T. Antoniou, M. Loutfy, 2007, AIDS patient care and STDs.

Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITAN.

C. Katlama, A. Rachlis, T. van de Casteele, 2012, Current HIV research.

Prediction of Health Preference Values from CD4 Counts in Individuals with HIV

S. Rourke, A. Rachlis, N. Mittmann, 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression

R. Hogg, J. Montaner, T. Antoniou, 2010, Journal of acquired immune deficiency syndromes.

Treatment Durability, Effectiveness, and Safety with Atazanavir/Ritonavir-Based HAART Regimen in Treatment-Naïve HIV-lnfected Patients

C. Tremblay, M. Loutfy, A. Rachlis, 2011, HIV clinical trials.

Long-Term Follow-up of a Cohort of HIV-Infected Patients Who Discontinued Maintenance Therapy for Cytomegalovirus Retinitis

J. Raboud, S. Walmsley, A. Rachlis, 2006, HIV clinical trials.

Switching from a Tenofovir Disoproxil Fumarate (TDF) to a Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen (STR): Week 48 Data in HIV-1-Infected Virologically Suppressed Adults

A. Lazzarin, A. Rachlis, A. Cheng, 2015 .

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Clare Brennan, Carlo Torti, Mark Bloch, 2013, The Lancet.

Management of antiretroviral- related neuropsychiatrics adverse effects

A. Rachlis, 2001 .

Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study.

J. Montaner, A. Rachlis, P. Renzi, 1991, Annals of internal medicine.

Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy

C. Kovacs, M. Loutfy, J. Raboud, 2003, HIV clinical trials.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Michael J Silverberg, Bryan Lau, Michael S Saag, 2009, The New England journal of medicine.

Monitoring Adverse Drug Reactions to Sulfonamide Antibiotics in Human Immunodeficiency Virus–Infected Individuals

E. Phillips, A. Rachlis, M. Neuman, 2002, Therapeutic drug monitoring.

Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.

R. Kaul, C. Kovacs, J. Raboud, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors

S. Trottier, J. Singer, C. Kovacs, 2016, Scientific Reports.

HIV Postexposure Prophylaxis Use Among Ontario Female Adolescent Sexual Assault Victims: A Prospective Analysis

Heather Husson, M. Loutfy, A. Rachlis, 2008, Sexually transmitted diseases.

Prospective Cohort Study of HIV Post-Exposure Prophylaxis for Sexual Assault Survivors

Heather Husson, T. Antoniou, M. Loutfy, 2008, Antiviral therapy.

Human Papillomavirus Type 16 Viral Load Is Higher in Human Immunodeficiency Virus-Seropositive Women with High-Grade Squamous Intraepithelial Lesions Than in Those with Normal Cytology Smears

A. Rachlis, F. Coutlée, C. Hankins, 2004, Journal of Clinical Microbiology.

The role of people living with HIV as patient instructors – reducing stigma and improving interest around HIV care among medical students*

N. McNaughton, A. Rachlis, A. Wagner, 2017, AIDS care.

Nosocomial Neisseria meningitidis Molecular Analysis of a Clinical Problem

A. Rachlis, M. Louie, A. Simor, 1997, Infection Control & Hospital Epidemiology.

Guidelines for antiretroviral therapy for HIV infection

A. Rachlis, D. Zarowny, 1998 .

HIV-positive Women Living in the Metropolitan Toronto Area: Their Experiences and Perceptions Related to HIV Testing

S. Strathdee, S. Walmsley, L. Jackson, 1997, Canadian Journal of Public Health.

One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States

Sally S Bebawy, Richard D Moore, Jennifer S. Lee, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study

T. Hart, M. Loutfy, J. Raboud, 2009, PloS one.

The impact of drug coverage on viral suppression among people living with HIV in Ontario, Canada

A. Burchell, S. Rourke, J. Raboud, 2018, Canadian Journal of Public Health.

Once Daily Dosing Improves Adherence to Antiretroviral Therapy

M. Loutfy, S. Rourke, J. Raboud, 2011, AIDS and Behavior.

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Richard D Moore, J. Goedert, B. Lau, 2015, Annals of internal medicine.

Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries

Curtis Cooper, Marek Smieja, P. Harrigan, 2010, BMC infectious diseases.

Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001–2011

A. Burchell, T. Antoniou, M. Loutfy, 2015, Journal of acquired immune deficiency syndromes.

Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort

P. Harrigan, B. Yip, R. Hogg, 2016, BMC Infectious Diseases.

Late presentation for human immunodeficiency virus care in the United States and Canada.

Richard D Moore, J. Goedert, Jeffrey N. Martin, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care

Lisa P. Barrett, V. Martel-Laferrière, J. Montaner, 2019, Open forum infectious diseases.

High incidence of bronchospasm with regular administration of aerosolized pentamidine.

K. Iglar, A. Rachlis, C. Chan, 1992, Chest.

American Journal of Epidemiology Practice of Epidemiology Missing Data on the Estimation of the Prevalence of Accumulated Human Immunodeficiency Virus Drug Resistance in Patients Treated with Antiretroviral Drugs in North America

Richard D Moore, J. Goedert, B. Lau, 2022 .

Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency.

O. Djurdjev, M. Wainberg, J. Freedman, 1998, AIDS research and human retroviruses.

Gastrointestinal Symptom Distress is Associated With Worse Mental and Physical Health-Related Quality of Life

T. Hart, A. Burchell, S. Rourke, 2017, Journal of acquired immune deficiency syndromes.

Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons

E. Moodie, V. Martel-Laferrière, S. Walmsley, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk of End‐Stage Renal Disease in HIV‐Positive Potential Live Kidney Donors

L. Kucirka, S. Boswell, M. Gill, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada.

Richard D Moore, Haiqun Lin, J. Brooks, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Richard D Moore, K. Anastos, S. Gange, 2019, The lancet. HIV.

A prospective comparison of Porta-sonic and Fisoneb ultrasonic nebulizers for administering aerosol pentamidine.

A. Rachlis, D. Flood, A. McIvor, 1994, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Risk factors for prophylaxis failure in patients receiving aerosol pentamidine for Pneumocystis carinii pneumonia prophylaxis.

A. Rachlis, C. Chan, S. Gardner, 2001, Chest.

An Effectiveness Community-Based Clinical Trial of Respirgard II and Fisoneb Nebulizers for Pneumocystis carinii Prophylaxis With Aerosol Pentamidine in HIV-Infected Individuals

A. Rachlis, Charles K. N. Chan, R. A. Mclvor, 1996 .

The long-term effects of aerosol pentamidine on pulmonary function. The Toronto Aerosolized Pentamidine Study (TAPS) Group.

A. Rachlis, E. Tullis, R. Hyland, 1992, Clinical and investigative medicine. Medecine clinique et experimentale.

Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study.

C. Kovacs, T. Marcotte, M. Gill, 2020, AIDS.

Hospital-wide rollout of antimicrobial stewardship: a stepped-wedge randomized trial.

T. Einarson, A. Rachlis, R. Pinto, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful implementation of a national HLA-B*5701 genetic testing service in Canada.

M. Gill, A. Rachlis, J. Angel, 2010, Tissue antigens.

Sexual Anxiety Among Women Living with HIV in the Era of Antiretroviral Treatment Suppressing HIV Transmission

S. Trottier, T. Hart, A. Burchell, 2020, Sexuality Research and Social Policy.

Lymphogranuloma venereum in North America: case reports and an update for gastroenterologists.

A. Rachlis, E. Hsieh, J. Tinmouth, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, R. Hogg, 2017, BMC Research Notes.

A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome

S. Trottier, J. Singer, M. Gill, 2006, European Journal of Clinical Nutrition.

Micronutrient Deficiency and Treatment Adherence in a Randomized Controlled Trial of Micronutrient Supplementation in ART-Naïve Persons with HIV

M. Gill, B. Conway, M. Loutfy, 2014, PloS one.

Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge design

A. Burchell, V. Allen, S. Rourke, 2015, Implementation Science.

General Management Strategies for Efavirenz Therapy and Associated Adverse Events

A. Rachlis, J. Baril, 2006 .

Canadian Expert Panel recommendations on the management of CNS symptoms related to efavirenz

M. Gill, S. Walmsley, A. Rachlis, 2001 .

Establishing the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study

S. Trottier, T. Hart, R. Hogg, 2016, BMC Medical Research Methodology.

Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen

S. Trottier, C. Kovacs, J. Sampalis, 2007, HIV clinical trials.

CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?

Richard D Moore, J. Goedert, Jeffrey N. Martin, 2010, AIDS research and therapy.

Development, implementation, and evaluation of a student-initiated undergraduate medical education elective in HIV care

S. Rourke, A. Rachlis, Denise Jaworsky, 2012, Medical teacher.

Using faculty and student perceptions of group dynamics to develop recommendations for PBL training

A. Rachlis, A R Rachlis, J. Tipping, 1995, Academic medicine : journal of the Association of American Medical Colleges.

Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients.

S. Walmsley, A. Rachlis, T. Mazzulli, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy

M. Gill, B. Conway, S. Walmsley, 2002, Annals of Internal Medicine.

Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception

M. Loutfy, L. Serghides, S. Walmsley, 2017, Journal of the International Association of Providers of AIDS Care.

Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States

Sally S Bebawy, Richard D Moore, K. Anastos, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

E. Moodie, V. Martel-Laferrière, J. Montaner, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature

T. Marcotte, M. Gill, S. Rourke, 2013, AIDS.

Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections

L. Mandell, A. Rachlis, R. Feld, 1988, Antimicrobial Agents and Chemotherapy.

‘Buffalo‐hump’ dermatitis: a hat trick of antiretroviral side‐effects

A. Rachlis, J. Sullivan, Pankaj Salphale, 2003, Contact dermatitis.

Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada

A. Burchell, T. Antoniou, M. Loutfy, 2017, AIDS care.

Mentoring Undergraduate Medical Students: A Study of Organizational Aspects

A. Rachlis, P. Poldre, 1997 .

Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials

S. Walmsley, F. Raffi, A. Rachlis, 2015, AIDS.

A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection

J. Margolick, J. Singer, J. Gallant, 2015, PloS one.

Ethnicity and Gender Differences in Lipodystrophy of HIV-Positive Individuals Taking Antiretroviral Therapy in Ontario, Canada

M. Loutfy, S. Rourke, J. Raboud, 2011, HIV clinical trials.

Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy

B. Yip, M. Wainberg, A. Burchell, 2017, HIV medicine.

Changes in hospital admissions pattern in patients with human immunodeficiency virus infection in the era of Pneumocystis carinii prophylaxis.

A. Rachlis, C. Chan, S. Mintz, 1992, Chest.

Severe acute respiratory syndrome: responses of the healthcare system to a global epidemic.

A. Rachlis, A. Marshall, Joseph Chen, 2005, Current opinion in otolaryngology & head and neck surgery.

Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS

A. Rachlis, F. Smaill, Amy Jones, 1999, PharmacoEconomics.

Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression?

Lisa P. Barrett, E. Moodie, V. Martel-Laferrière, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults.

A. Rachlis, J. Angel, M. Harris, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

The Use of Multistate Models to Examine Associations of Stress and Adherence With Transitions Among HIV Care States Observed in a Clinical HIV Cohort

A. Burchell, T. Antoniou, M. Loutfy, 2017, Journal of acquired immune deficiency syndromes.

Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience.

M. Loeb, L. Fernando, N. Bastien, 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Self-Reported Preconception Care of HIV-Positive Women of Reproductive Potential

T. Hart, M. Loutfy, J. Raboud, 2014, Journal of the International Association of Providers of AIDS Care.

Neurologic manifestations of HIV infection. Using imaging studies and antiviral therapy effectively.

A. Rachlis, 1998, Postgraduate medicine.

Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients.

C. Tremblay, S. Walmsley, A. Rachlis, 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Didanosine Compared with Continued Zidovudine Therapy for HIV-Infected Patients with 200 to 500 CD4 Cells/mm3: A Double-Blind, Randomized, Controlled Trial

M. Wainberg, M. Schechter, H. Salomón, 1995, Annals of Internal Medicine.

Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort

S. Rourke, S. Knowles, A. Rachlis, 2012, American Journal of Clinical Dermatology.

Progress of HIV infection and changes in the lipid membrane structure of CD4+ cells.

M. Bast, A. Rachlis, A. Klein, 1992, AIDS.

Residents as teachers: time for formal training.

W. Weston, A. Rachlis, H. Batty, 2002, Canadian family physician Medecin de famille canadien.

Five cases of erroneously diagnosed HIV infection.

M. Gill, A. Rachlis, C. Anand, 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

High prevalence of unintended pregnancies in HIV‐positive women of reproductive age in Ontario, Canada: a retrospective study

T. Hart, M. Loutfy, J. Raboud, 2012, HIV medicine.

HIV clinical trials are not enough.

M. Millson, A. Rachlis, 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

Victor C. M. Leung, L. C. Medina, David J. Smith, 2019, Journal of the International AIDS Society.

Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment

Richard D Moore, T. Sterling, D. Dowdy, 2016, Journal of acquired immune deficiency syndromes.

Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein?

E. Phillips, A. Rachlis, S. Ito, 2003, AIDS.

Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group.

W. Rozenbaum, A. Rachlis, S. Danner, 1997, The Journal of infectious diseases.

Clindamycin in human breast milk.

A. Rachlis, J. A. Smith, F. Papsin, 1975, Canadian Medical Association journal.

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

Sally S Bebawy, Richard D Moore, J. Goedert, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection

K. Tashima, S. Staszewski, D. Skiest, 2008, AIDS.

The new england journal of medicine Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

J. Goedert, B. Lau, R. Hogg, 2009 .

Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.

A. Rachlis, J. Hurwitz, N. Fine, 1999, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

A. Ferenczy, J. Raboud, S. Walmsley, 2013, The Journal of infectious diseases.

Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide.

P. Harrigan, J. Montaner, D. Rouleau, 2007, Antiviral research.

Impact of acid-suppressive therapy on virologic response to atazanavir-based regimens in antiretroviral-experienced patients: a case series.

T. Antoniou, M. Loutfy, A. Rachlis, 2005, Journal of acquired immune deficiency syndromes.

Ethnicity and Gender Differences in Lipodystrophy of HIV-Positive Individuals Taking Antiretroviral Therapy in Ontario, Canada

M. Loutfy, S. Rourke, J. Raboud, 2011, HIV clinical trials.

Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.

R. Kaul, C. Kovacs, J. Raboud, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.

J. Goedert, B. Lau, R. Hogg, 2011, American Journal of Epidemiology.

Impact of Age on Retention in Care and Viral Suppression

K. Anastos, A. Burchell, M. Gill, 2015, Journal of acquired immune deficiency syndromes.

Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals

I. James, S. Mallal, J. Montaner, 2008 .